The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men

Published:2015-05-24 Issue:1 Volume:117 Page:72-79
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Boegemann Martin¹,Stephan Carsten²³,Cammann Henning⁴,Vincendeau Sébastien⁵,Houlgatte Alain⁶,Jung Klaus²³,Blanchet Jean-Sebastien⁷,Semjonow Axel¹

Affiliation:

1. Department of Urology; Prostate Center; University Medical Centre; Münster Germany

2. Department of Urology; Charité - Universitätsmedizin Berlin; Berlin Germany

3. Berlin Institute for Urologic Research; Berlin Germany

4. Institute of Medical Informatics; Charité - Universitätsmedizin Berlin; Berlin Germany

5. Department of Urology; Hospital Pontchallou; Rennes France

6. Department of Urology; HIA du Val de Grâce; Paris France

7. Department of Scientific Affairs; Beckman Coulter Eurocenter; Nyon Switzerland

Funder

Supporting Association of the Prostate Center Münster

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13139/fullpdf

Reference41 articles.

1. International variation in prostate cancer incidence and mortality rates;Center;Eur Urol,2012

2. New data on prostate-cancer mortality after PSA screening;Miller;N Engl J Med,2012

3. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;J Natl Cancer Inst,2003

4. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening;Etzioni;Ann Intern Med,2013

5. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force;Chou;Ann Intern Med,2011

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer risk prediction based on clinical factors and prostate-specific antigen;BMC Urology;2023-06-03

2. A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer;Cancers;2023-02-21

3. Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Open Science;2022-12

4. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review;BMJ Open;2022-04

5. Índice de Salud Prostática (phi);Medicina y Laboratorio;2022-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3